| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 5705196 | Ophthalmology | 2017 | 9 Pages |
Abstract
Intravitreal injection of ranibizumab seemed to be effective in treating patients with ROP. After treatment, there were primarily 3 different outcomes. Our predictive tree model is helpful for ophthalmologists to evaluate the risk of reactivation.
Keywords
Related Topics
Health Sciences
Medicine and Dentistry
Ophthalmology
Authors
Qiujing MD, Qi MD, Ping MD, PhD, Yu MD, PhD, Jiao MD, Xunda MD, Jie MD, Yi-an MD, Peiquan MD,